Lunar (Scientific & Regulatory Affairs Associate Director) and Sara Sánchez Vidaurre (Scientific
& Regulatory Affairs Officer) learnt more about recent advances in biomarkers in rheumatic disorders. Marta
talked about regulatory considerations of biomarkers qualification for clinical
significant challenges remain, progress continues to be made in biomarker
discovery and development for rheumatic diseases.
Asphalion will keep you informed!